FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Clarification Sought in Informed Consent Guidance

[ Price : $8.95]

Commenters suggest ways to improve an FDA draft informed consent information sheet guidance.

Reps. Concerned About Generic Drug Labeling Proposal

[ Price : $8.95]

Reps. Israel and Bishop says an FDA proposed rule changing generic drug labels could severely harm the industry.

Custom Device Exemption Guidance

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance: Custom Device Exemption.

Unreasonable Patients Spur LASIK Harm Reports: FDA Contractor

[ Price : $8.95]

A U.S. Navy contractor to FDA who studied quality of life issues in LASIK patients publishes an article saying unreasonable expect...

Shire Settles False Claims Case for $56.5 Million

[ Price : $8.95]

Shire Pharmaceuticals agrees to pay the U.S. government $56.5 million to resolve civil allegations that it violated the False Clai...

More Detail, Clarity Sought in Biosimilarity Guidance

[ Price : $8.95]

The International Consortium for Innovation and Quality calls on FDA to add more detail and clarity to a draft guidance on clinica...

Veterinary ICH Guidance on Blood Level Bioequivalence

[ Price : $8.95]

Federal Register Notice: FDA is making available a draft guidance on harmonizing the data recommendations associated with in vivo ...

FDA Clears Expanded Nova Glucose Meter Indication

[ Price : $8.95]

FDA clears an expanded indication for Nova Biomedicals StatStrip glucose hospital meter system for use with critically ill patient...

CDER Guidance Coming on Quality Metrics Initiative

[ Price : $8.95]

CDER says it will publish a draft guidance on its Quality Metrics Initiative by the end of the year.

FDA Aims to Curb Drug Buying from Rogue Wholesalers

[ Price : $8.95]

FDA launches a new educational program to protect healthcare professionals from purchasing potentially unsafe drug products from a...